Clinical Trial Update: A New Pathway With BronchOscopic or Oesophageal Ultrasound for Lung Cancer Diagnosis and STaging (BOOST) [Phase 3]

View source ↗

Summary

A Phase 3 trial named BOOST assesses the use of bronchoscopic or esophageal ultrasound as a diagnostic and staging pathway for lung cancer. The study status is …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer

Snippet

Sponsor: University College London Hospitals | Conditions: Bronchogenic Carcinoma | Phase 3 | Status: COMPLETED